Lori Martin Gregory

Lori Martin Gregory is a reluctant activist who uses her background as a strategic consultant and fourth generation journalist to promote health freedom.

She was graduated with a BA in Journalism from Metropolitan State College in Denver and an MBA from Boston University. She also has a diploma in Complementary Medicines from The Open University in Sri Lanka and has been teaching Ayurveda, yoga, and meditation for 25 years.

She previously worked on Wall Street as an investor relations consultant for biotech and pharma, and is now a serial entrepreneur in the natural health space. She is also the editor and publisher of The Mom Street Journal and is a regular contributor to The War Room with Owen Shroyer and Roger Stone. She was selected as one of 13 on the 2019 Roger Stone Annual International Best Dressed List.

Dr. Andrew J. Rochman is a NY Board-Certified Surgeon and a leader in advanced surgical techniques. He is a graduate of Colgate University and received his formal medical training from Nordestana University in 1981. He is an active member of the American Medical Association, the Medical Society of the State of New York, Nassau County Medical Society and the American College of Phlebology. Dr. Rochman currently manages several practices in the specialized sciences of advanced vein therapy, gallbladder surgery and stem cell therapy.

In 2005, Dr. Rochman opened his private practice called ADVANCED VEIN CARE SOLUTIONS in Plainview, NY – for the treatment of vascular issues and disorders where he is recognized for his expertise in treating the full range of vein disease conditions using today’s most advanced diagnostic and treatment approaches.

In 2015, Dr. Rochman pursued training and received certification from U.S. Stem Cell for a comprehensive cellular regeneration program which led to the establishment of his second private practice – CELLULAR THERAPIES OF NY (CTNY). Here, he brings the advancements of stem cell therapy treatments to patients with musculoskeletal issues such as arthritis, knee/elbow & shoulder injuries. By the fall of 2017, CTNY underwent a major upgrade of its treatment capabilities and resources to promote the treatment of a wider variety of disorders from: COPD, Degenerative Disc Disease, Auto-Immune Diseases and Neurological disorders such as Multiple Sclerosis & Parkinson’s Disease.

Kristin Comella, PhD

Dr. Comella is a world-renowned expert on regenerative medicine with a focus on adipose derived stem cells. She was named number 24 on Terrapin’s list of the Top 50 Global Stem Cell Influencers and number 1 on the Academy of Regenerative Practices list of Top 10 Stem Cell Innovators. Most recently, Dr. Comella made the list of Top 50 Functional and Integrative Medical Doctors/Scientists in the country by DrAxe.com, one of the most visited natural health websites in the world.
Dr. Comella has pioneered stem cell therapies from various sources including cord blood, bone marrow, muscle, and adipose. She led the team that gained the first ever FDA approval for a clinical trial using a combined cell and gene therapy product in the heart. In addition to advanced cell culturing experience, Dr. Comella has managed the development, manufacturing, and quality systems of a variety of cellular products. She has developed a wide range of regenerative techniques and products that have now been successfully implemented into the clinic setting. Her professional experience includes positions in several companies including US Stem Cell, VetBiologics, Tulane University and Osiris Therapeutics. Dr. Comella progressed from research engineer at Osiris Therapeutics developing stem cell therapies for osteoarthritis to building and managing the stem cell laboratory at Tulane University’s Center for Gene Therapy. She was the co-founder and Chief Executive Officer of Stemlogix, a regenerative medicine company focusing on veterinary medicine.

She is currently serving as the Chief Scientific Officer and board member of US Stem Cell, a publicly traded company focusing on the discovery, development, and commercialization of autologous cell therapies for the treatment of degenerative diseases. She has been responsible for the development and implementation of cell therapies in the clinic for a variety of different indications for more than 7000 patients. Hundreds of practitioners world-wide have provided stem cell treatments to their patients using her protocols. Dr. Comella has a PhD in Stem Cell Biology and holds both an MS and BS in Chemical Engineering.


Share This